We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




POC Blood Test Analyzer Performs CBC in Five Minutes

By LabMedica International staff writers
Posted on 23 May 2022
Print article
Image: HemoScreen POC blood test analyzer makes testing simple and accessible anywhere (Photo courtesy of PixCell Medical)
Image: HemoScreen POC blood test analyzer makes testing simple and accessible anywhere (Photo courtesy of PixCell Medical)

The world's first and only lab-quality, portable plug-and-play Complete Blood Count (CBC) analyzer allows real-time blood testing to be performed by anyone, anywhere, providing critical health data on the spot. This facilitates fast diagnostic results and data-driven disease management decisions.

PixCell Medical Technologies, Ltd.’s (Yokne'am Illit, Israel) HemoScreen hematology analyzer is the only 5-part differential CBC analyzer that is FDA-cleared, CE-marked and TGA-approved for point-of-care use offers clinically proven lab-accurate readings of 20 standard blood count parameters within five minutes, with just one finger-prick of blood. PixCell's HemoScreen delivers lab-accurate diagnostic information that alloes healthcare professionals to make rapid and clinically reliable decisions supported by real-time data.

The portable point of care hematology analyzer combines flow cytometry and digital imaging in a single platform for CBC and WBC 5-part differential. HemoScreen employs a patented, disposable cartridge preloaded with all necessary reagents. This reduces reagent waste and eliminates the need for maintenance and calibration, providing CBC results as well as comprehensive abnormal cell flagging for earlier detection of infection and certain cancer types.

“PixCell has transformed routine blood testing by combining novel microfluidics, machine learning and AI into a point-of-care instrument that anyone can operate,” said Dr. Avishay Bransky, co-founder and CEO of PixCell Medical. “Our breakthrough technology is allowing lab-grade testing to become independent from central laboratories and highly skilled experts, putting data in the hands of the medical staff who need it most, when they need it and where they need it.”

Related Links:
PixCell Medical Technologies, Ltd. 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Myeloperoxidase Assay
IDK MPO ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.